Infectious Diseases Market Research Reports & Industry Analysis
Infectious Diseases Industry Research & Market Reports
-
Chagas Disease: American trypanosomiasis Market
... a detailed competitive environment analysis. The scope of this report covers treatment throughout Latin America. Report Includes: An overview of the global chagas disease (T. cruzi infection) market Analyses of the global market trends, with ... Read More
-
Immunotherapy Drugs Market (Drug Type: Monoclonal Antibodies, Immunomodulators, Cell Therapy and Others; and Therapy Area: Cancer, Autoimmune Diseases, Infectious Diseases, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
... Market – Scope of Report TMR’s report on the global immunotherapy drugs market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Central Nervous System Therapeutics Market by Diseases (Cancer, Degenerative Diseases, Infectious Diseases), Drug Class (Analgesics, Anesthetics, Anti-Epileptics), End-Users - Global Forecast 2024-2030
... in 2023 and expected to reach USD 76.41 billion in 2024, at a CAGR 9.37% to reach USD 131.39 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Central ... Read More
-
Bovine Respiratory Disease Treatment Market by Disease Type (Diphtheria, Pneumonia, Upper Respiratory Tract Infections), Treatment Type (Antibiotics, Immunomodulators, Vaccines), Distribution Channel - Global Forecast 2024-2030
... USD 1.96 billion in 2023 and expected to reach USD 2.10 billion in 2024, at a CAGR 7.58% to reach USD 3.27 billion by 2030. Global Bovine Respiratory Disease Treatment Market FPNV Positioning Matrix The ... Read More
-
Antisense & RNAi Therapeutics Market by Technology (Antisense RNA, RNA Interference), Application (Cardiovascular Diseases (CVDs), Genetic Disorders, Infectious Diseases), Route of Administration - Global Forecast 2024-2030
... at USD 4.51 billion in 2023 and expected to reach USD 4.93 billion in 2024, at a CAGR 9.34% to reach USD 8.43 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Digital Respiratory Devices Market by Product (Sensors & Apps, Smart Inhalers & Nebulizers), Disease Indications (Asthma, COPD, Infectious Diseases), Distribution Channel, End-Use - Global Forecast 2024-2030
... USD 23.45 billion in 2023 and expected to reach USD 30.61 billion in 2024, at a CAGR 30.95% to reach USD 154.87 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
In Silico Clinical Trials Market by Therapeutic Area (Infectious Diseases, Oncology), Phase (Phase I, Phase II, Phase III), Industry - Global Forecast 2024-2030
... billion in 2023 and expected to reach USD 3.19 billion in 2024, at a CAGR 7.01% to reach USD 4.85 billion by 2030. Global In Silico Clinical Trials Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Biologics Market by Product (Cellular Based Biologics, Gene Based Biologics, Monoclonal Antibodies), Indication (Autoimmune Diseases, Cancer, Infectious Diseases), End-user - Global Forecast 2024-2030
... and expected to reach USD 302.68 billion in 2024, at a CAGR 5.39% to reach USD 415.18 billion by 2030. Global Biologics Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the ... Read More
-
Infectious Disease Therapeutics Market by Drug (Antibiotics, Antifungal Drugs, Antiparasitic Drugs), Route of Administration (Intravenous, Oral, Topical), Disease, Distribution Channel, End-User - Global Forecast 2024-2030
... 116.21 billion in 2023 and expected to reach USD 121.27 billion in 2024, at a CAGR 4.41% to reach USD 157.28 billion by 2030. Global Infectious Disease Therapeutics Market FPNV Positioning Matrix The FPNV Positioning ... Read More
-
Pneumonia Testing Market by Type (Instruments, Reagents & Consumables), Method (Immunodiagnostics, Molecular Diagnostics, Point of Care Testing), Technology, End-user - Global Forecast 2024-2030
... 2023 and expected to reach USD 1.58 billion in 2024, at a CAGR 6.23% to reach USD 2.28 billion by 2030. Global Pneumonia Testing Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in ... Read More
-
Auto-disable Syringes Market by Indication (Infectious Diseases, Inflammatory/Auto-Immune Diseases), Application (Blood Collection, Drug Delivery, Vaccination), End-User - Global Forecast 2024-2030
... to reach USD 25.94 billion in 2024, at a CAGR 11.54% to reach USD 50.01 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Auto-disable Syringes Market. It offers ... Read More
-
Therapeutic Vaccines Market by Vaccines Type (Auto-Immune Diseases Vaccines, Chronic Disease Vaccines, Infectious Diseases Vaccines), Disease Indication (Dengue, DTP, Hepatitis), Administration, End-User - Global Forecast 2024-2030
... 30.08 billion in 2023 and expected to reach USD 33.05 billion in 2024, at a CAGR 10.35% to reach USD 59.95 billion by 2030. Global Therapeutic Vaccines Market FPNV Positioning Matrix The FPNV Positioning Matrix ... Read More
-
mRNA Vaccines in Infectious Diseases Market Overview
... Current Companies and Brief Market Outlook Messenger RNA (mRNA) is a single-stranded ribonucleic acid that is transcribed from a strand of DNA. mRNA carries the coding information for protein synthesis. mRNA vaccines use mRNA that ... Read More
-
Companion Diagnostics Market, By Technology Type (Real Time-Polymerase Chain Reactions (PCR), Gene Sequencing, Fluorescence in situ Hybridization, and Others) By Application (Oncology, Cardiovascular Diseases, Infectious Diseases, Neurological Diseases and Others), By End User (Hospitals, Research Laboratories, Biopharmaceutical companies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Laboratories, Biopharmaceutical companies, and Others), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) Companion diagnostics are medical devices that are used to detect specific biomarkers or genes in patients that ... Read More
-
Global Nontuberculous Mycobacterial Infections Market 2024-2028
... mycobacterial infections market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market ... Read More
-
West Nile Virus Market, By Product Type (Antivirals, Vaccines, Antibiotics, Analgesics, and Others), By Route of Administration (Oral, Injectable, Topical), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
... Pacific, Latin America, Middle East, and Africa) West Nile virus (WNV) is a mosquito-borne disease that affects humans, birds, and other animals. It was first identified in the West Nile region of Uganda in 1937 ... Read More
-
North America Digital Thoracic Drainage Devices Market Forecast to 2030 - Regional Analysis - by Product Type (Single Chamber and Multiple Chambers), Application (Cardiac Surgery, Thoracic and Pulmonary Surgery, Oncology and Trauma, Infectious Diseases, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)
... Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others) The North America digital thoracic drainage devices market is expected to grow from US$ 51.10 million in 2022 to US$ 77.70 million by 2030. It ... Read More
-
Cell And Gene Therapy CDMO Market Size, Share & Trends Analysis Report By Phase (Pre-clinical, Clinical), By Product Type (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Indication (Oncology, Infectious Diseases), By Region, And Segment Forec
... Forec Cell And Gene Therapy CDMO Market Growth & Trends The global cell and gene therapy CDMO market size is expected to reach USD 27.45 billion by 2030 and is projected to grow at a ... Read More
-
Lipid Nanoparticle Manufacturing Market: Services and Technologies, 2023-2035 - Distribution by Type of Lipid Nanoparticle (Solid Lipid Nanoparticles and Nanostructured Lipid Carriers), Type of Molecule Delivered (Nucleic Acids, Small Molecules, Proteins/Peptides and Others), Company Size (Very Large and Large, Mid-sized and Small), Target Therapeutic Area (Infectious Diseases, Oncological Disorders, Blood Disorders, Rare Diseases and Other Disorders), Type of End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End-users) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts
... (Very Large and Large, Mid-sized and Small), Target Therapeutic Area (Infectious Diseases, Oncological Disorders, Blood Disorders, Rare Diseases and Other Disorders), Type of End-user (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, and Other End-users) ... Read More
-
Pneumonia Treatment Drugs Companies in China
... expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in ... Read More
-
Pneumonia Treatment Drugs Industry Forecasts - China Focus
... of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the world’s major producers for industrial and consumer products. Far outpacing other economies in the ... Read More
-
ELISpot and FluoroSpot Assay Market by Product (Assay kit (Technique, Utility, Analyte (T Cell and B Cell assay)), Analyzer), Application (Transplants, Infectious Diseases, Vaccine Development, Cancer Research), End User - Global Forecast to 2028
... global ELISpot and FluoroSpot Assays Market is expected to reach USD 421 million by 2028 from USD 292 million in 2023, at a CAGR of 7.6% during the forecast period. Market is driven by factors ... Read More
-
Physician Office Diagnostic Market, By Product Type (Point-of-Care Testing (POCT) Devices, Clinical Chemistry Analyzers, Immunoassay Systems, Molecular Diagnostics, and Urinalysis Systems), By End User (Physician Offices and Clinics, Urgent Care Centers, and Ambulatory Care Centers), By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... By Application (Infectious Diseases, Cardiovascular Disorders, Metabolic Disorders, Cancer Diagnosis, Pregnancy and Fertility Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) POCT enables quick and accurate diagnostic testing with ... Read More
-
Orphan Drugs Market Forecasts to 2030 – Global Analysis By Disease Type (Oncological Diseases, Metabolic Diseases, Hematologic & Immunologic Diseases, Infectious diseases and Neurological diseases), Drug Type (Non-Biologics and Biologics), Sale, Drug, Distribution Channel and By Geography
... By Geography According to Stratistics MRC, the Global Orphan Drugs Market is accounted for $175.8 billion in 2023 and is expected to reach $445.5 billion by 2030 growing at a CAGR of 14.2% during the ... Read More
-
Global Hospital Hygiene Management Market - Analysis and Forecast, 2022-2032
... ongoing COVID-19 pandemic. This report provides an in-depth analysis of the evolving landscape of hospital hygiene management, with a specific focus on new innovations in the industry. The three key areas of innovation discussed in ... Read More
Research Assistance
